In short. Ingredients rather than technique determine what you are buying. How to read a mesotherapy plan as a list, and what each part of it is worth asking about.
Key points
- Some ingredients arrive as licensed products with a named use.
- Others are compounded or prepared for the occasion.
- Both may be offered, and they are not the same thing, because a prepared mixture has not been assessed as a mixture.
Two clinics can offer mesotherapy, inject completely different things and both be accurate. The technique is the same and the treatment is not. So the useful question is not what the treatment is called but what is in it, and the useful answer is a list rather than a name.
What the lists usually contain
At one end sits a single substance that has been studied when placed into the skin. In the middle sit combinations of vitamins, minerals and amino acids, widely used and thinly studied, whose individual ingredients may have evidence in other contexts and whose combination has almost none. At the other end sit plant extracts and dilutions with no plausible mechanism. All three are sold under the same word, and the study record of the first says nothing about the third.
Ask which parts are licensed and which are prepared
Some ingredients arrive as licensed products with a named use. Others are compounded or prepared for the occasion. Both may be offered, and they are not the same thing, because a prepared mixture has not been assessed as a mixture. Ask what that means for the quality control behind your plan.
Why the list matters more than the label
A list can be checked against your history. It can be compared with what you have had before, it can be set against medication you take, and it can be written into a record that a clinician reads if a lump appears months later. A treatment name can do none of those things, and the practical difference shows up at exactly the moment you need it. The list is also what makes a second opinion possible, since no clinician can review a plan whose contents are a slogan.
What the list does not tell you
A list is a starting point rather than a promise. Knowing the substances does not tell you whether they will do anything, because for most combinations nobody knows, and it does not tell you how long any change will last, because it fades between sessions. What it does is separate the parts of the offer you can reason about from the parts you cannot.
Ask who prepared it
A mixture assembled in a pharmacy, a product drawn from its own packaging, and something prepared in a treatment room are three different things, and only one of them arrives with a manufacturer behind it. Ask which one you are being offered, and what that means for how it was made.
These are reasons to ask again before agreeing
- That the contents are described only as a proprietary blend.
- That the evidence for one ingredient is presented as covering the whole mixture.
- That no version of the plan can be given to you in writing.
What the study record can and cannot support is set out in What the Evidence Supports, and the risks that come with a mixture are covered in Infection, Allergy and Nodules.
Frequently asked questions
What substances are typically used in these mixtures?
The range is wide and includes single substances that have been studied when injected into the skin, vitamins, minerals and amino acids used in combination, plant extracts, and dilutions with no plausible mechanism. Because the combinations are not standardised, a description of one mixture tells you very little about the next one.
Is a longer ingredient list a better treatment?
No, and it carries its own risks. Every additional ingredient is an additional chance of a reaction, and a longer list is harder to check against your allergies and medication. A short list of things that have been studied is a more defensible plan than a long list of things that have not.
How should I ask about the contents without sounding difficult?
Ask for the plan in writing as a list of substances, then ask which of them are licensed products and which are prepared for the occasion. Those are ordinary questions with factual answers, and a clinic that treats them as distrust has told you something about how the rest of the conversation will go.
Risks & Limitations
- Mesotherapy names a technique, not a product. The mixture is often prepared rather than manufactured, and it has not been assessed as a mixture.
- Any change reported is usually modest, lies in surface quality rather than in volume, and fades without further sessions.
- Firm lumps and delayed reactions can appear weeks to months after a session, and the date they appear is part of how they are assessed.
- A mixture is not standardised between clinics or between sessions, so the evidence for one plan says nothing about the next.
When to Seek Care
- Severe pain out of proportion to the procedure, or skin turning white, grey, mottled or dusky, needs immediate assessment.
- Any change in vision after an injection requires emergency care.
- Fever, or redness, warmth or discharge at a treated area that is spreading rather than settling.
- A firm lump or nodule appearing weeks or months later, which should be reported when noticed rather than at a review.
References & Further Reading
- American Society of Plastic Surgeons (ASPS) — procedure and safety guidance
- National Institute for Health and Care Excellence (NICE, UK) — relevant guidance
- Cochrane Library — systematic reviews
- Chinese Medical Association Plastic Surgery Branch — clinical guidance
This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.